News

Moderna study shows immune response in older adults for a combo flu and COVID-19 shot
A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...
US FDA advisers to discuss COVID-19 vaccine recommendations on May 22
The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts on May 22 to discuss COVID-19 ...
Federal judge orders Trump administration to unblock pandemic relief money for schools
Officials in sixteen states and the District of Columbia sued in response, leading to Tuesday’s order from U.S. District ...
Moderna: Combo flu-COVID shot works in older adults
A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...
1NVAX : Uncovering Potential: Novavax's Earnings Preview
Analysts are estimating that Novavax will report an earnings per share (EPS) of $0.19. The market awaits Novavax's ...
Barron's4d
Novavax Inc.
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in ...
Dermatology Advisor5d
Novavax COVID Vaccine Moves Closer to Full FDA Approval
The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval.